Specialty Innovation

Specialty Innovation (SI) is a healthcare technology and clinical research company that operates as a core division of Specialty Networks, which was acquired by Cardinal Health in early 2024. The company leverages real-world data (RWD) and advanced analytics to support clinical trial design, patient identification, and commercialization strategies for pharmaceutical and biotech partners. Specialty Innovation focuses primarily on specialty therapeutic areas such as urology, gastroenterology, and rheumatology, utilizing a vast network of independent physician practices. By integrating clinical data with practice management solutions, the company accelerates the development and delivery of specialty therapeutics. Their services include retrospective data studies, prospective clinical trials, and patient engagement programs designed to improve outcomes in complex disease states.